Search - tctmd.com

Displaying 401 - 420 of 660

Sort: Relevancy | Date

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

News Daily News

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Michael O'Riordan

January 03, 2019

News Features

Top News in Prevention: 2018

Michael O'Riordan

December 28, 2018

News Daily News

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Michael O'Riordan

December 24, 2018

News Daily News

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

Shelley Wood

December 18, 2018

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Daily News

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Caitlin E. Cox

November 21, 2018

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Caitlin E. Cox

November 15, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News AHA 2018

AHA Puts Focus on the Impact of Violence on Cardiovascular Health

Todd Neale

November 14, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News AHA 2018

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Caitlin E. Cox

November 13, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

News Daily News

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Michael O'Riordan

November 07, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

Advertisement

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Top News in Prevention: 2018

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

AHA Puts Focus on the Impact of Violence on Cardiovascular Health

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content